Art

J-GLOBAL ID：201802240596925900   Reference number：18A0780143

Neutrophil-to-lymphocyte ratio after pazopanib treatment predicts response in patients with advanced soft-tissue sarcoma

パゾパニブ療法後の好中球対リンパ球比は進行性軟組織肉腫患者における反応を予測する

Author (14)： KOBAYASHI Hiroshi (Univ. Tokyo Hospital, Tokyo, JPN) ,  OKUMA Tomotake (Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, JPN) ,  OKA Hiroyuki (Univ. Tokyo Hospital, Tokyo, JPN) ,  HIRAI Toshihide (Univ. Tokyo Hospital, Tokyo, JPN) ,  OHKI Takahiro (Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, JPN) ,  IKEGAMI Masachika (Univ. Tokyo Hospital, Tokyo, JPN) ,  SAWADA Ryoko (Univ. Tokyo Hospital, Tokyo, JPN) ,  SHINODA Yusuke (Univ. Tokyo Hospital, Tokyo, JPN) ,  AKIYAMA Toru (Jichi Medical Univ., Saitama, JPN) ,  SATO Kenji (Univ. Teikyo, Tokyo, JPN) ,  ABE Satoshi (Univ. Teikyo, Tokyo, JPN) ,  KAWANO Hirotaka (Univ. Teikyo, Tokyo, JPN) ,  GOTO Takahiro (Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, JPN) ,  TANAKA Sakae (Univ. Tokyo Hospital, Tokyo, JPN)
Material： International Journal of Clinical Oncology  (Int J Clin Oncol)
Volume： 23  Issue： 2  Page： 368-374  Publication year： Apr. 2018 
JST Material Number： L3966A  ISSN： 1341-9625  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： *ratio ,...
Semi thesaurus term： *N/L ratio ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0780143&from=J-GLOBAL&jstjournalNo=L3966A") }}

JST classification (1)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Substance index (1)： Pazopanib

Reference (32)：

• Clark MA, Fisher C, Judson I et al (2005) Soft-tissue sarcomas in adults. N Engl J Med 353:701-711
• Byerly S, Chopra S, Nassif NA et al (2016) The role of margins in extremity soft tissue sarcoma. J Surg Oncol 113:333-338
• Callegaro D, Miceli R, Bonvalot S et al (2016) Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis. Lancet Oncol 17:671-680
• van der Graaf WT, Blay JY, Chawla SP et al (2012) Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomized, double-blind, placebo-controlled phase 3 trial. Lancet 379:1879-1886
• Schöffski P, Chawla S, Maki RG et al (2016) Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial. Lancet 387:1629-1637

Terms in the title (8)： パゾパニブ ,  療法 ,  好中球 ,  リンパ球 ,  軟組織 ,  肉腫 ,  患者 ,  予測